Can the dosage of vaccine against TBE is optimized by means of changes in dosing interval for those over 50 years

Trial Profile

Can the dosage of vaccine against TBE is optimized by means of changes in dosing interval for those over 50 years

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Tick-borne encephalitis vaccine (Primary)
  • Indications Encephalitis virus infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 30 Jan 2014 Planned number of patients changed from 350 to 250 as reported by European Clinical Trials Database.
    • 13 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top